These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22318020)

  • 1. UK government unveils innovation booster.
    Moran N
    Nat Biotechnol; 2012 Feb; 30(2):125. PubMed ID: 22318020
    [No Abstract]   [Full Text] [Related]  

  • 2. Massachusetts: Mass effect.
    Savage N
    Nature; 2016 Sep; 537(7618):S18-9. PubMed ID: 27580137
    [No Abstract]   [Full Text] [Related]  

  • 3. The changing norms of the life sciences.
    Shorett P; Rabinow P; Billings PR
    Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827
    [No Abstract]   [Full Text] [Related]  

  • 4. UK research funding.
    Nat Cell Biol; 2009 Apr; 11(4):363. PubMed ID: 19337316
    [No Abstract]   [Full Text] [Related]  

  • 5. UK government lobbying for increased spending on universities intensifies.
    Birmingham K
    Nat Med; 1998 May; 4(5):539. PubMed ID: 9585210
    [No Abstract]   [Full Text] [Related]  

  • 6. Investment in innovation: lessons learned from China.
    Wiederhold BK
    Cyberpsychol Behav Soc Netw; 2011 Apr; 14(4):181-2. PubMed ID: 21486173
    [No Abstract]   [Full Text] [Related]  

  • 7. Italian biologists left out in the cold.
    Abbott A
    Nature; 2001 Feb; 409(6821):652. PubMed ID: 11217825
    [No Abstract]   [Full Text] [Related]  

  • 8. Recriminations inflame UK research debate.
    Adam D
    Nature; 2002 Jul; 418(6893):6. PubMed ID: 12097875
    [No Abstract]   [Full Text] [Related]  

  • 9. New tax credit program aims to revive ailing biotech research.
    Clin Transl Sci; 2010 Oct; 3(5):200. PubMed ID: 21500422
    [No Abstract]   [Full Text] [Related]  

  • 10. The Bayh-Dole Act turns 30.
    Loise V; Stevens AJ
    Sci Transl Med; 2010 Oct; 2(52):52cm27. PubMed ID: 20926832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commercial backing 'could impair academic influence'.
    Wadman M
    Nature; 1996 Dec; 384(6609):501. PubMed ID: 8955258
    [No Abstract]   [Full Text] [Related]  

  • 12. Start-ups: A sense of enterprise.
    Savage N
    Nature; 2016 May; 533(7601):S10-2. PubMed ID: 27144602
    [No Abstract]   [Full Text] [Related]  

  • 13. Business pressure mounts.
    Williams N
    Curr Biol; 2004 Jan; 14(2):R47-8. PubMed ID: 14738742
    [No Abstract]   [Full Text] [Related]  

  • 14. Basic instincts.
    Nat Nanotechnol; 2008 Feb; 3(2):59. PubMed ID: 18654454
    [No Abstract]   [Full Text] [Related]  

  • 15. The technology trap.
    Gewin V
    Nature; 2005 Oct; 437(7061):948-9. PubMed ID: 16222269
    [No Abstract]   [Full Text] [Related]  

  • 16. Tax change curtails UK university spin-offs.
    Giles J
    Nature; 2004 May; 429(6987):6. PubMed ID: 15129245
    [No Abstract]   [Full Text] [Related]  

  • 17. Product development. And the winner is...
    Mooney H
    Health Serv J; 2012 Apr; 122(6303):Suppl 26-7. PubMed ID: 22741365
    [No Abstract]   [Full Text] [Related]  

  • 18. France. Will French science swallow Zerhouni's strong medicine?
    Enserink M
    Science; 2008 Nov; 322(5906):1312. PubMed ID: 19039109
    [No Abstract]   [Full Text] [Related]  

  • 19. Product development: case studies. A new dimension.
    Health Serv J; 2012 Apr; 122(6303):Suppl 28-9. PubMed ID: 22741366
    [No Abstract]   [Full Text] [Related]  

  • 20. Taking knowledge from bench to bank.
    Horton B; Wickware P; Gershon D; Gavaghan H
    Nature; 1998 Sep; 395(6700):409-14. PubMed ID: 9759734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.